Register Cart 0

Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Back Subscribe

Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer

Author(s): Alberto Ocana, Rosario Serrano, Raul Calero and Atanasio Pandiella

Volume 10, Issue 6, 2009

Page: [575 - 576] Pages: 2

DOI: 10.2174/138945009788488378

Price: $65

Abstract

Full text available

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

4

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Biodistribution, Safety and Organ Toxicity of Docetaxel-Loaded in HER-2 Aptamer Conjugated Ecoflex® Nanoparticles in a Mouse Xenograft Model of Ovarian Cancer
Recent Patents on Nanotechnology

p42.3 in Gastric Carcinoma: A Novel Biomarker and Promising Therapeutic Target
Letters in Drug Design & Discovery

Treatment Related Morbidity in Cervical Cancer
Current Women`s Health Reviews

Comprehensive Profiling of the Low Molecular Weight Proteins and Peptides in Weak Cation Exchange Beads Human Serum Retentate
Protein & Peptide Letters

Editorial (Mini-Thematic Issue: Morphological and Molecular Backgrounds for Personalized Therapies in Genitourinary Cancers)
Current Drug Targets

Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer
Current Cancer Drug Targets

Macrophage-Assisted Inflammation and Pharmacological Regulation of the Cholinergic Anti-Inflammatory Pathway
Current Medicinal Chemistry

Pharmacological Targeting of the Inflamed Intestinal Barrier
Current Pharmaceutical Design

Genetic Polymorphism and Tumor Immunotherapy
Current Pharmacogenomics

Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015
Current Clinical Pharmacology

TNF-α/Cycloheximide-Induced Oxidative Stress and Apoptosis in Murine Intestinal Epithelial MODE-K Cells
Current Pharmaceutical Design

Therapeutic Enhancement of IL-2 Through Molecular Design
Current Pharmaceutical Design

Hypoglycemic Agents in the Management of Type 2 Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)

Transferrin and the Transferrin Receptor: Of Magic Bullets and Other Concerns
Inflammation & Allergy - Drug Targets (Discontinued)

TRIM65 in White Matter Lesions, Innate Immunity, and Tumor
Current Molecular Pharmacology

Melanoma Differentiation Associated Gene-7 (mda-7)/ Interleukin-24 (IL-24), mda-7/IL-24: Current Perspectives on a Unique Member of the IL-10 Family of Cytokines
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Proteomics Approach to Illustrate Drug Action Mechanisms
Current Drug Discovery Technologies

Heterodimeric Amino Acid Transporters: Molecular Biology and Pathological and Pharmacological Relevance
Current Drug Metabolism

Surgical Management of Mullerian Duct Anomalies
Current Women`s Health Reviews

2-Deoxy-D-Ribose, a Downstream Mediator of Thymidine Phosphorylase, Regulates Tumor Angiogenesis and Progression
Anti-Cancer Agents in Medicinal Chemistry

© 2025 Bentham Science Publishers | Privacy Policy